[1] Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician, 2005; 72, 1761-8. http://www.aafp.org/afp/2005/1101/p1761.html
[2] Wright CA, Hesseling AC, Bamford C, et al. Fine-needle aspiration biopsy: a first-line diagnostic procedure in paediatric tuberculosis suspects with peripheral lymphadenopathy? Int J Tuberc Lung Dis, 2009; 13, 1373-9. https://www.cabdirect.org/cabdirect/abstract/20093359510
[3] Abdissa K, Tadesse M, Bezabih M, et al. Bacteriological methods as add on tests to fine-needle aspiration cytology in diagnosis of tuberculous lymphadenitis: can they reduce the diagnostic dilemma? BMC Infect Dis, 2014; 14, 720. doi:  10.1186/s12879-014-0720-z
[4] Denkinger CM, Schumacher SG, Boehme CC, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2014; 44, 435-46. doi:  10.1183/09031936.00007814
[5] Kaur G, Dhamija A, Augustine J, et al. Can cytomorphology of granulomas distinguish sarcoidosis from tuberculosis? Retrospective study of endobronchial ultrasound guided transbronchial needle aspirate of 49 granulomatous lymph nodes. Cytojournal, 2013; 10, 19. doi:  10.4103/1742-6413.119008
[6] Narang S, Solanki A, Kashyap S, et al. Utility of fine needle aspiration cytology to comprehend the pathogenesis of extrapulmonary tuberculosis. Diagn Cytopathol, 2016; 44, 98-102. doi:  10.1002/dc.23403
[7] Peter JG, Theron G, Pooran A, et al. Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial. Lancet Respir Med, 2013; 1, 471-8. doi:  10.1016/S2213-2600(13)70120-6
[8] Onal IK, Cankurtaran M, Cakar M, et al. Fever of unknown origin: what is remarkable in the elderly in a developing country? J Infect, 2006; 52, 399-404. doi:  10.1016/j.jinf.2005.08.021
[9] Micheletti VC, Kritski AL, Braga JU. Clinical Features and Treatment Outcomes of Patients with Drug-Resistant and Drug-Sensitive Tuberculosis: A Historical Cohort Study in Porto Alegre, Brazil. PLoS One, 2016; 11, e0160109. doi:  10.1371/journal.pone.0160109
[10] Velayutham BV, Allaudeen IS, Sivaramakrishnan GN, et al. Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India. Clin Infect Dis, 2014; 59, e142-9. doi:  10.1093/cid/ciu550
[11] World Health Organization, Global tuberculosis report 2014, WHO Press: Geneva, Switzerland, 2014.
[12] World Health Organization, Global tuberculosis report 2015, WHO Press: Geneva, Switzerland, 2015.
[13] Brown CS, Smith CJ, Breen RA, et al. Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control study. BMC Infect Dis, 2016; 16, 479. doi:  10.1186/s12879-016-1816-4
[14] Rajendra A, Sabnis K, Jeyaseelan V, et al. Paradoxical reaction (PR) in tuberculous lymphadenitis among HIV-negative patients: retrospective cohort study. Postgrad Med J, 2016; pii: postgradmedj-2016-134326. http://pmj.bmj.com/content/92/1093/684
[15] Munkhdelger J, Wang HY, Choi Y, et al. Identification of Mycobacterium species in FFPE granulomatous lymphadenitis tissue using REBA Myco-ID®. Int J Tuberc Lung Dis, 2013; 17, 898-902. doi:  10.5588/ijtld.12.0818
[16] Fu YC, Liao IC, Chen HM, et al. Detection of Mycobacterium tuberculosis Complex in Paraffin-Embedded Tissues by the New Automated Abbott RealTime MTB Assay. Ann Clin Lab Sci, 2016; 46, 412-7. https://www.ncbi.nlm.nih.gov/pubmed/27466302
[17] Meghdadi H, Khosravi AD, Ghadiri AA, et al. Detection of Mycobacterium tuberculosis in extrapulmonary biopsy samples using PCR targeting IS6110, rpoB, and nested-rpoB PCR Cloning. Front Microbiol, 2015; 6, 675. https://www.researchgate.net/publication/280220144_Detection_of_Mycobacterium_tuberculosis_in_extrapulmonary_biopsy_samples_using_PCR_targeting_IS6110_rpoB_and_nested-rpoB_PCR_Cloning
[18] Gupta AK, Nayar M, Chandra M. Critical appraisal of fine needle aspiration cytology in tuberculous lymphadenitis. Acta Cytol, 1992; 36, 391-4. http://europepmc.org/abstract/MED/1580124
[19] Che N, Qu Y, Zhang C, et al. Double staining of bacilli and antigen Ag85B improves the accuracy of the pathological diagnosis of pulmonary tuberculosis. J Clin Pathol, 2016; 69, 600-6. doi:  10.1136/jclinpath-2015-203244
[20] Tadesse M, Abebe G, Abdissa K, et al. GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings. PLoS One, 2015; 10, e0137471. doi:  10.1371/journal.pone.0137471
[21] World Health Organization, Treatment of tuberculosis: guidelines -4th ed, WHO Press: Geneva, Switzerland, 2010.
[22] Boyles TH, Hughes J, Cox V, et al. False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results. Int J Tuberc Lung Dis, 2014; 18, 876-8. doi:  10.5588/ijtld.13.0853
[23] Lanéelle MA, Daffé M. Transport assays and permeability in pathogenic mycobacteria. Methods Mol Biol, 2009; 465, 143-51. doi:  10.1007/978-1-59745-207-6
[24] Chandrasekhar S, Ratnam S. Studies on cell-wall deficient non-acid fast variants of Mycobacterium tuberculosis. Tuber Lung Dis, 1992; 73, 273-9. doi:  10.1016/0962-8479(92)90132-4
[25] Seiler P, Ulrichs T, Bandermann S, et al. Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection. J Infect Dis, 2003; 188, 1326-31. doi:  10.1086/jid.2003.188.issue-9